Case Report

Published on 23 Sep 2021

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation

in Cancer Immunity and Immunotherapy

Jianfeng Peng
Xianguang Zhao
Kaikai Zhao
Xiangjiao Meng

Frontiers in Oncology

doi 10.3389/fonc.2021.731429

2,733 views
6 citations

Systematic Review

Published on 23 Sep 2021

The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Hui Liu
Xiao-Li Yang
Xiao-Yun Yang
Zhao-Ru Dong
Zhi-Qiang Chen
Jian-Guo Hong
Tao Li

Frontiers in Oncology

doi 10.3389/fonc.2021.691002

2,287 views
11 citations

Mini Review

Published on 23 Sep 2021

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer

in Cancer Immunity and Immunotherapy

Ivan Y. Filin
Kristina V. Kitaeva
Catrin S. Rutland
Albert A. Rizvanov
Valeriya V. Solovyeva

Frontiers in Oncology

doi 10.3389/fonc.2021.730824

14,572 views
48 citations

Review

Published on 23 Sep 2021

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Wenxiang Zhang
Xiangyi Kong
Bolun Ai
Zhongzhao Wang
Xiangyu Wang
Nianchang Wang
Shan Zheng
Yi Fang
Jing Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.582664

5,473 views
18 citations

Case Report

Published on 22 Sep 2021

Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy

in Cancer Immunity and Immunotherapy

Chen Hu
Qiang Ma
Nengsheng Li
Nuo Luo
Shuai Hao
Minrui Jiang
Fei Pang
Yan Yang
Li Li
Yong He

Frontiers in Oncology

doi 10.3389/fonc.2021.693704

2,167 views
4 citations

Review

Published on 21 Sep 2021

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities

in Cancer Immunity and Immunotherapy

Robert Saddawi-Konefka
Aaron B. Simon
Whitney Sumner
Andrew Sharabi
Loren K. Mell
Ezra E. W. Cohen

Frontiers in Oncology

doi 10.3389/fonc.2021.738626

3,921 views
15 citations

Original Research

Published on 20 Sep 2021

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI

in Cancer Immunity and Immunotherapy

Haiyi Deng
Xinqing Lin
Xiaohong Xie
Yilin Yang
Liqiang Wang
Jianhui Wu
Ming Liu
Zhanhong Xie
Yinyin Qin
Chengzhi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.700023

3,609 views
6 citations

Review

Published on 17 Sep 2021

Immunotherapeutic Potential of T Memory Stem Cells

in Cancer Immunity and Immunotherapy

Yujie Li
Dengqiang Wu
Xuejia Yang
Sufang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.723888

13,880 views
26 citations

Original Research

Published on 17 Sep 2021

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study

in Cancer Immunity and Immunotherapy

Hirva Mamdani
Bryan Schneider
Susan M. Perkins
Heather N. Burney
Pashtoon Murtaza Kasi
Laith I. Abushahin
Thomas Birdas
Kenneth Kesler
Tracy M. Watkins
Sunil S. Badve

Frontiers in Oncology

doi 10.3389/fonc.2021.736620

6,377 views
29 citations

Original Research

Published on 15 Sep 2021

Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers

in Cancer Immunity and Immunotherapy

Zhenyu Yang
Yulan Deng
Jiahan Cheng
Shiyou Wei
Hao Luo
Lunxu Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.695006

8,727 views
15 citations

Original Research

Published on 15 Sep 2021

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma

in Cancer Immunity and Immunotherapy

Ye Nie
Jianhui Li
Wenlong Wu
Dongnan Guo
Xinjun Lei
Tianchen Zhang
Yanfang Wang
Zhenzhen Mao
Xuan Zhang
Wenjie Song

Frontiers in Oncology

doi 10.3389/fonc.2021.706915

4,986 views
8 citations

Systematic Review

Published on 15 Sep 2021

Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Zhe Zhao
Xinfeng Wang
Jinghan Qu
Wei Zuo
Yan Tang
Huijuan Zhu
Xiaoguang Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.708195

4,464 views
28 citations

Original Research

Published on 14 Sep 2021

Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression

in Cancer Immunity and Immunotherapy

Min Wang
Jie Zhu
Fang Zhao
Jiani Xiao

Frontiers in Oncology

doi 10.3389/fonc.2021.643503

3,875 views
4 citations

Review

Published on 13 Sep 2021

Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Bolei Li
Tao Gong
Yu Hao
Xuedong Zhou
Lei Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.721249

5,721 views
7 citations

Original Research

Published on 10 Sep 2021

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma

in Cancer Immunity and Immunotherapy

Huimin Wang
Xiaoang Yang
Guiying Sun
Qian Yang
Chi Cui
Xiao Wang
Hua Ye
Liping Dai
Jianxiang Shi
Jianying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.661043

2,587 views
4 citations

Original Research

Published on 10 Sep 2021

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

in Cancer Immunity and Immunotherapy

Radhika Thokala
Zev A. Binder
Yibo Yin
Logan Zhang
Jiasi Vicky Zhang
Daniel Y. Zhang
Michael C. Milone
Guo-li Ming
Hongjun Song
Donald M. O’Rourke

Frontiers in Oncology

doi 10.3389/fonc.2021.664236

6,201 views
21 citations

Navigation group

Articles

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation

The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy

Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities

Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI

Immunotherapeutic Potential of T Memory Stem Cells

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study

Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma

Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis

Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression

Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms